STOCK TITAN

Nevro to Present at Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nevro Corp. (NYSE: NVRO), a leading medical device company, will be represented by Chairman, CEO, and President D. Keith Grossman at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 11:45 AM Eastern Time. Investors can access a live webcast and an archived recording of the presentation on Nevro's website. The company specializes in innovative solutions for chronic pain treatment, including its proprietary Senza spinal cord stimulation systems.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Aug. 25, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 11:45 am Eastern Time / 8:45 am Pacific Time.

A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com.

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com.  The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Senza, Senza II, Senza Omnia, HFX, HXF Coach, HFX Cloud, HFX Connect, Nevro and the Nevro logo are trademarks of Nevro Corp.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Vice President, Investor Relations & Corp Communications
650-433-3247  |  julie.dewey@nevro.com

.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-to-present-at-morgan-stanley-19th-annual-global-healthcare-conference-301360162.html

SOURCE Nevro Corp.

FAQ

What is the date and time of Nevro's presentation at the Morgan Stanley Conference?

Nevro will present on September 13, 2021, at 11:45 AM Eastern Time.

Where can I find the webcast of Nevro's presentation?

The webcast will be available in the Investors section of Nevro's website.

What is the focus of Nevro Corp.?

Nevro specializes in innovative medical devices for the treatment of chronic pain.

What kind of systems does Nevro offer for pain management?

Nevro offers the Senza, Senza II, and Senza Omnia spinal cord stimulation systems.

What is 10 kHz Therapy associated with Nevro?

10 kHz Therapy is Nevro's proprietary neuromodulation technology for chronic pain treatment.

NEVRO CORP.

NYSE:NVRO

NVRO Rankings

NVRO Latest News

NVRO Stock Data

216.24M
37.28M
3.73%
96.48%
8.4%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY